Abstract
Lactic acid bacteria (LAB) have a long-term history of use in food industry and are becoming attractive for use in therapy on account of their safety, intrinsic beneficial health effects, and considerable biotechnological potential. The established systems for engineering are combined with novel approaches, such as CRISPR-Cas, to enable the use of LAB as vectors for delivery of various therapeutic molecules. The latter are either secreted or surface displayed and can be used for the treatment or prevention of numerous conditions: inflammatory bowel diseases, infections, autoimmune diseases, and even cancer. This review presents some recent data on engineering of LAB, with the emphasis on the most commonly used genera Lactococcus and Lactobacillus. Their use for the delivery of therapeutic proteins is discussed, while a special focus is given to the delivery of therapeutic peptides. Therapeutically relevant improvements of engineered LAB, such as containment systems, ability to visualize bacteria, or target specific host cells are also addressed. Future engineering of LAB for therapy will adopt the capabilities of synthetic biology, with first examples already emerging.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
ActoBio Therapeutics I (2018) ActoBio Therapeutics™ doses first patient in phase Ib/IIa clinical study of AG019 for the treatment of type 1 diabetes. PW Newswire. https://www.prnewswire.com/news-releases/actobio-therapeutics-doses-first-patient-in-phase-ibiia-clinical-study-of-ag019-for-the-treatment-of-type-1-diabetes-300739137.html. Accessed 29 Oct 2018
Arora T, Wegmann U, Bobhate A, Lee YS, Greiner TU, Drucker DJ, Narbad A, Backhed F (2016) Microbially produced glucagon-like peptide 1 improves glucose tolerance in mice. Mol Metab 5(8):725–730
de Azevedo M, Karczewski J, Lefevre F, Azevedo V, Miyoshi A, Wells JM, Langella P, Chatel JM (2012) In vitro and in vivo characterization of DNA delivery using recombinant Lactococcus lactis expressing a mutated form of L. monocytogenes Internalin a. BMC Microbiol 12:299
Bahey-El-Din M, Gahan CG (2011) Lactococcus lactis-based vaccines: current status and future perspectives. Hum Vaccin 7(1):106–109
Bahey-El-Din M, Casey PG, Griffin BT, Gahan CG (2010) Efficacy of a Lactococcus lactis DeltapyrG vaccine delivery platform expressing chromosomally integrated hly from Listeria monocytogenes. Bioeng Bugs 1(1):66–74. https://doi.org/10.4161/bbug.1.1.10284
Baradaran A, Yusoff K, Shafee N, Rahim RA (2016) Newcastle disease virus hemagglutinin neuraminidase as a potential cancer targeting agent. J Cancer 7(4):462–466
Benbouziane B, Ribelles P, Aubry C, Martin R, Kharrat P, Riazi A, Langella P, Bermudez-Humaran LG (2013) Development of a stress-inducible controlled expression (SICE) system in Lactococcus lactis for the production and delivery of therapeutic molecules at mucosal surfaces. J Biotechnol 168(2):120–129. https://doi.org/10.1016/j.jbiotec.2013.04.019
Berlec A, Malovrh T, Zadravec P, Steyer A, Ravnikar M, Sabotic J, Poljsak-Prijatelj M, Strukelj B (2013) Expression of a hepatitis a virus antigen in Lactococcus lactis and Escherichia coli and evaluation of its immunogenicity. Appl Microbiol Biotechnol 97(10):4333–4342
Berlec A, Zavrsnik J, Butinar M, Turk B, Strukelj B (2015) In vivo imaging of Lactococcus lactis, Lactobacillus plantarum and Escherichia coli expressing infrared fluorescent protein in mice. Microb Cell Factories 14:181. https://doi.org/10.1186/s12934-015-0376-4
Berlec A, Skrlec K, Kocjan J, Olenic M, Strukelj B (2018) Single plasmid systems for inducible dual protein expression and for CRISPR-Cas9/CRISPRi gene regulation in lactic acid bacterium Lactococcus lactis. Sci Rep 8(1):1009. https://doi.org/10.1038/s41598-018-19402-1
Bermudez-Humaran LG, Motta JP, Aubry C, Kharrat P, Rous-Martin L, Sallenave JM, Deraison C, Vergnolle N, Langella P (2015) Serine protease inhibitors protect better than IL-10 and TGF-beta anti-inflammatory cytokines against mouse colitis when delivered by recombinant lactococci. Microb Cell Factories 14:26. https://doi.org/10.1186/s12934-015-0198-4
Bober JR, Beisel CL, Nair NU (2018) Synthetic biology approaches to engineer probiotics and members of the human microbiota for biomedical applications. Annu Rev Biomed Eng 20:277–300. https://doi.org/10.1146/annurev-bioeng-062117-121019
Bonisch E, Oh YJ, Anzengruber J, Hager FF, Lopez-Guzman A, Zayni S, Hinterdorfer P, Kosma P, Messner P, Duda KA, Schaffer C (2018) Lipoteichoic acid mediates binding of a Lactobacillus S-layer protein. Glycobiology 28(3):148–158. https://doi.org/10.1093/glycob/cwx102
Borrero J, Chen Y, Dunny GM, Kaznessis YN (2015) Modified lactic acid bacteria detect and inhibit multiresistant enterococci. ACS Synth Biol 4(3):299–306
Braat H, Rottiers P, Hommes DW, Huyghebaert N, Remaut E, Remon JP, van Deventer SJ, Neirynck S, Peppelenbosch MP, Steidler L (2006) A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn’s disease. Clin Gastroenterol Hepatol 4(6):754–759. https://doi.org/10.1016/j.cgh.2006.03.028
Bron PA, Kleerebezem M (2018) Lactic acid bacteria for delivery of endogenous or engineered therapeutic molecules. Front Microbiol 9:1821. https://doi.org/10.3389/fmicb.2018.01821
Brophy JA, Voigt CA (2014) Principles of genetic circuit design. Nat Methods 11(5):508–520. https://doi.org/10.1038/nmeth.2926
Call EK, Klaenhammer TR (2013) Relevance and application of sortase and sortase-dependent proteins in lactic acid bacteria. Front Microbiol 4:73. https://doi.org/10.3389/fmicb.2013.00073
Caluwaerts S, Vandenbroucke K, Steidler L, Neirynck S, Vanhoenacker P, Corveleyn S, Watkins B, Sonis S, Coulie B, Rottiers P (2010) AG013, a mouth rinse formulation of Lactococcus lactis secreting human trefoil factor 1, provides a safe and efficacious therapeutic tool for treating oral mucositis. Oral Oncol 46(7):564–570
Cameron DE, Collins JJ (2014) Tunable protein degradation in bacteria. Nat Biotechnol 32(12):1276–1281
Cano-Garrido O, Seras-Franzoso J, Garcia-Fruitos E (2015) Lactic acid bacteria: reviewing the potential of a promising delivery live vector for biomedical purposes. Microb Cell Factories 14:137. https://doi.org/10.1186/s12934-015-0313-6
Cao HP, Wang HN, Yang X, Zhang AY, Li X, Ding MD, Liu ST, Zhang ZK, Yang F (2013) Lactococcus lactis anchoring avian infectious bronchitis virus multi-epitope peptide EpiC induced specific immune responses in chickens. Biosci Biotechnol Biochem 77(7):1499–1504
Carroll IM, Andrus JM, Bruno-Barcena JM, Klaenhammer TR, Hassan HM, Threadgill DS (2007) Anti-inflammatory properties of Lactobacillus gasseri expressing manganese superoxide dismutase using the interleukin 10-deficient mouse model of colitis. Am J Physiol Gastrointest Liver Physiol 293(4):G729–G738. https://doi.org/10.1152/ajpgi.00132.2007
Chamcha V, Jones A, Quigley BR, Scott JR, Amara RR (2015) Oral immunization with a recombinant Lactococcus lactis-expressing HIV-1 antigen on group a Streptococcus pilus induces strong mucosal immunity in the gut. J Immunol 195(10):5025–5034
Chancey CJ, Khanna KV, Seegers JF, Zhang GW, Hildreth J, Langan A, Markham RB (2006) Lactobacilli-expressed single-chain variable fragment (scFv) specific for intercellular adhesion molecule 1 (ICAM-1) blocks cell-associated HIV-1 transmission across a cervical epithelial monolayer. J Immunol 176(9):5627–5636
Chowdhury MY, Li R, Kim JH, Park ME, Kim TH, Pathinayake P, Weeratunga P, Song MK, Son HY, Hong SP, Sung MH, Lee JS, Kim CJ (2014) Mucosal vaccination with recombinant Lactobacillus casei-displayed CTA1-conjugated consensus matrix protein-2 (sM2) induces broad protection against divergent influenza subtypes in BALB/c mice. PLoS One 9(4):e94051. https://doi.org/10.1371/journal.pone.0094051
Daniel C, Repa A, Wild C, Pollak A, Pot B, Breiteneder H, Wiedermann U, Mercenier A (2006) Modulation of allergic immune responses by mucosal application of recombinant lactic acid bacteria producing the major birch pollen allergen bet v 1. Allergy 61(7):812–819. https://doi.org/10.1111/j.1398-9995.2006.01071.x
Daniel C, Repa A, Mercenier A, Wiedermann U, Wells J (2007) The European LABDEL project and its relevance to the prevention and treatment of allergies. Allergy 62(11):1237–1242. https://doi.org/10.1111/j.1398-9995.2007.01496.x
Daniel C, Poiret S, Dennin V, Boutillier D, Pot B (2013) Bioluminescence imaging study of spatial and temporal persistence of Lactobacillus plantarum and Lactococcus lactis in living mice. Appl Environ Microbiol 79(4):1086–1094. https://doi.org/10.1128/AEM.03221-12
Daniel C, Titecat M, Poiret S, Cayet D, Boutillier D, Simonet M, Sirard JC, Lemaitre N, Sebbane F (2016) Characterization of the protective immune response to Yersinia pseudotuberculosis infection in mice vaccinated with an LcrV-secreting strain of Lactococcus lactis. Vaccine 34(47):5762–5767
Danino T, Prindle A, Kwong GA, Skalak M, Li H, Allen K, Hasty J, Bhatia SN (2015) Programmable probiotics for detection of cancer in urine. Sci Transl Med 7(289):289ra84. https://doi.org/10.1126/scitranslmed.aaa3519
Del Carmen S, de Moreno de LeBlanc A, Levit R, Azevedo V, Langella P, Bermudez-Humaran LG, LeBlanc JG (2017) Anti-cancer effect of lactic acid bacteria expressing antioxidant enzymes or IL-10 in a colorectal cancer mouse model. Int Immunopharmacol 42:122–129. https://doi.org/10.1016/j.intimp.2016.11.017
Dieye Y, Usai S, Clier F, Gruss A, Piard JC (2001) Design of a protein-targeting system for lactic acid bacteria. J Bacteriol 183(14):4157–4166
Doudna JA, Charpentier E (2014) Genome editing. The new frontier of genome engineering with CRISPR-Cas9. Science 346(6213):1258096. https://doi.org/10.1126/science.1258096
van der Els S, James JK, Kleerebezem M, Bron PA (2018) Development of a versatile Cas9-driven subpopulation-selection toolbox in Lactococcus lactis. Appl Environ Microbiol. https://doi.org/10.1128/aem.02752-17
Fernandez de Palencia P, Nieto C, Acebo P, Espinosa M, Lopez P (2000) Expression of green fluorescent protein in Lactococcus lactis. FEMS Microbiol Immunol 183(2):229–234
Garcia-Cayuela T, de Cadinanos LP, Mohedano ML, de Palencia PF, Boden D, Wells J, Pelaez C, Lopez P, Requena T (2012) Fluorescent protein vectors for promoter analysis in lactic acid bacteria and Escherichia coli. Appl Microbiol Biotechnol 96(1):171–181
Habimana O, Le Goff C, Juillard V, Bellon-Fontaine MN, Buist G, Kulakauskas S, Briandet R (2007) Positive role of cell wall anchored proteinase PrtP in adhesion of lactococci. BMC Microbiol 7:36
Hanson ML, Hixon JA, Li W, Felber BK, Anver MR, Stewart CA, Janelsins BM, Datta SK, Shen W, McLean MH, Durum SK (2014) Oral delivery of IL-27 recombinant bacteria attenuates immune colitis in mice. Gastroenterology 146(1):210–221 e13. https://doi.org/10.1053/j.gastro.2013.09.060
Heine SJ, Franco-Mahecha OL, Chen X, Choudhari S, Blackwelder WC, van Roosmalen ML, Leenhouts K, Picking WL, Pasetti MF (2015) Shigella IpaB and IpaD displayed on L. lactis bacterium-like particles induce protective immunity in adult and infant mice. Immunol Cell Biol 93(7):641–652
Huibregtse IL, Snoeck V, de Creus A, Braat H, De Jong EC, Van Deventer SJ, Rottiers P (2007) Induction of ovalbumin-specific tolerance by oral administration of Lactococcus lactis secreting ovalbumin. Gastroenterology 133(2):517–528. https://doi.org/10.1053/j.gastro.2007.04.073
Huynh E, Li J (2015) Generation of Lactococcus lactis capable of coexpressing epidermal growth factor and trefoil factor to enhance in vitro wound healing. Appl Microbiol Biotechnol 99(11):4667–4677
Innocentin S, Guimaraes V, Miyoshi A, Azevedo V, Langella P, Chatel JM, Lefevre F (2009) Lactococcus lactis expressing either Staphylococcus aureus fibronectin-binding protein a or Listeria monocytogenes internalin a can efficiently internalize and deliver DNA in human epithelial cells. Appl Environ Microbiol 75(14):4870–4878
Kajikawa A, Zhang L, Long J, Nordone S, Stoeker L, LaVoy A, Bumgardner S, Klaenhammer T, Dean G (2012) Construction and immunological evaluation of dual cell surface display of HIV-1 gag and Salmonella enterica serovar Typhimurium FliC in Lactobacillus acidophilus for vaccine delivery. Clin Vaccine Immunol 19(9):1374–1381. https://doi.org/10.1128/CVI.00049-12
Karimi S, Ahl D, Vagesjo E, Holm L, Phillipson M, Jonsson H, Roos S (2016) In vivo and in vitro detection of luminescent and fluorescent Lactobacillus reuteri and application of red fluorescent mCherry for assessing plasmid persistence. PLoS One 11(3):e0151969. https://doi.org/10.1371/journal.pone.0151969
Karlskas IL, Maudal K, Axelsson L, Rud I, Eijsink VG, Mathiesen G (2014) Heterologous protein secretion in lactobacilli with modified pSIP vectors. PLoS One 9(3):e91125. https://doi.org/10.1371/journal.pone.0091125
Kasarello K, Szczepankowska A, Kwiatkowska-Patzer B, Lipkowski AW, Gadamski R, Sulejczak D, Lachwa M, Bialy M, Bardowski J (2016) Effect of recombinant Lactococcus lactis producing myelin peptides on neuroimmunological changes in rats with experimental allergic encephalomyelitis. Folia Neuropathol 54(3):249–258
Kawana K, Adachi K, Kojima S, Taguchi A, Tomio K, Yamashita A, Nishida H, Nagasaka K, Arimoto T, Yokoyama T, Wada-Hiraike O, Oda K, Sewaki T, Osuga Y, Fujii T (2014) Oral vaccination against HPV E7 for treatment of cervical intraepithelial neoplasia grade 3 (CIN3) elicits E7-specific mucosal immunity in the cervix of CIN3 patients. Vaccine 32(47):6233–6239. https://doi.org/10.1016/j.vaccine.2014.09.020
Kobierecka PA, Olech B, Ksiazek M, Derlatka K, Adamska I, Majewski PM, Jagusztyn-Krynicka EK, Wyszynska AK (2016) Cell wall anchoring of the Campylobacter antigens to Lactococcus lactis. Front Microbiol 7:165. https://doi.org/10.3389/fmicb.2016.00165
Kong W, Blanchard AE, Liao C, Lu T (2017) Engineering robust and tunable spatial structures with synthetic gene circuits. Nucleic Acids Res 45(2):1005–1014
Kosler S, Strukelj B, Berlec A (2017) Lactic acid bacteria with concomitant IL-17, IL-23 and TNFalpha-binding ability for the treatment of inflammatory bowel disease. Curr Pharm Biotechnol 18(4):318–326. https://doi.org/10.2174/1389201018666170210152218
Kuipers A, Rink R, Moll GN (2009) Translocation of a thioether-bridged azurin peptide fragment via the sec pathway in Lactococcus lactis. Appl Environ Microbiol 75(11):3800–3802
Kyla-Nikkila K, Alakuijala U, Saris PE (2010) Immobilization of Lactococcus lactis to cellulosic material by cellulose-binding domain of Cellvibrio japonicus. J Appl Microbiol 109(4):1274–1283. https://doi.org/10.1111/j.1365-2672.2010.04757.x
Le Loir Y, Nouaille S, Commissaire J, Bretigny L, Gruss A, Langella P (2001) Signal peptide and propeptide optimization for heterologous protein secretion in Lactococcus lactis. Appl Environ Microbiol 67(9):4119–4127
Leenay RT, Vento JM, Shah M, Martino ME, Leulier F, Beisel CL (2018) Genome editing with CRISPR-Cas9 in Lactobacillus plantarum revealed that editing outcomes can vary across strains and between methods. Biotechnol J e1700583. https://doi.org/10.1002/biot.201700583
Lei H, Peng X, Ouyang J, Zhao D, Jiao H, Shu H, Ge X (2015) Protective immunity against influenza H5N1 virus challenge in chickens by oral administration of recombinant Lactococcus lactis expressing neuraminidase. BMC Vet Res 11:85. https://doi.org/10.1186/s12917-015-0399-4
Li Y, Li X, Liu H, Zhuang S, Yang J, Zhang F (2014) Intranasal immunization with recombinant Lactococci carrying human papillomavirus E7 protein and mouse interleukin-12 DNA induces E7-specific antitumor effects in C57BL/6 mice. Oncol Lett 7(2):576–582. https://doi.org/10.3892/ol.2013.1743
Li HS, Piao DC, Jiang T, Bok JD, Cho CS, Lee YS, Kang SK, Choi YJ (2015) Recombinant interleukin 6 with M cell-targeting moiety produced in Lactococcus lactis IL1403 as a potent mucosal adjuvant for peroral immunization. Vaccine 33(16):1959–1967
Liang J, Aihua Z, Yu W, Yong L, Jingjing L (2010) HSP65 serves as an immunogenic carrier for a diabetogenic peptide P277 inducing anti-inflammatory immune response in NOD mice by nasal administration. Vaccine 28(19):3312–3317
Limaye SA, Haddad RI, Cilli F, Sonis ST, Colevas AD, Brennan MT, Hu KS, Murphy BA (2013) Phase 1b, multicenter, single blinded, placebo-controlled, sequential dose escalation study to assess the safety and tolerability of topically applied AG013 in subjects with locally advanced head and neck cancer receiving induction chemotherapy. Cancer 119(24):4268–4276. https://doi.org/10.1002/cncr.28365
Lin Y, Krogh-Andersen K, Pelletier J, Marcotte H, Ostenson CG, Hammarstrom L (2016) Oral delivery of pentameric glucagon-like peptide-1 by recombinant Lactobacillus in diabetic rats. PLoS One 11(9):e0162733. https://doi.org/10.1371/journal.pone.0162733
Linares DM, Alvarez-Sieiro P, del Rio B, Ladero V, Redruello B, Martin MC, Fernandez M, Alvarez MA (2015) Implementation of the agmatine-controlled expression system for inducible gene expression in Lactococcus lactis. Microb Cell Factories 14:208
Lindholm A, Smeds A, Palva A (2004) Receptor binding domain of Escherichia coli F18 fimbrial adhesin FedF can be both efficiently secreted and surface displayed in a functional form in Lactococcus lactis. Appl Environ Microbiol 70(4):2061–2071
Liu S, Li Y, Deng B, Xu Z (2016) Recombinant Lactococcus lactis expressing porcine insulin-like growth factor I ameliorates DSS-induced colitis in mice. BMC Biotechnol 16:25
Liu L, Zhang W, Song Y, Wang W, Zhang Y, Wang T, Li K, Pan Q, Qi X, Gao Y, Gao L, Liu C, Wang Y, He G, Wang X, Cui H (2018) Recombinant Lactococcus lactis co-expressing OmpH of an M cell-targeting ligand and IBDV-VP2 protein provide immunological protection in chickens. Vaccine 36(5):729–735
Llull D, Poquet I (2004) New expression system tightly controlled by zinc availability in Lactococcus lactis. Appl Environ Microbiol 70(9):5398–5406. https://doi.org/10.1128/AEM.70.9.5398-5406.2004
Lu WW, Wang T, Wang Y, Xin M, Kong J (2016) A food-grade fimbrial adhesin FaeG expression system in Lactococcus lactis and Lactobacillus casei. Can J Microbiol 62(3):241–248
Ma Y, Liu J, Hou J, Dong Y, Lu Y, Jin L, Cao R, Li T, Wu J (2014) Oral administration of recombinant Lactococcus lactis expressing HSP65 and tandemly repeated P277 reduces the incidence of type I diabetes in non-obese diabetic mice. PLoS One 9(8):e105701. https://doi.org/10.1371/journal.pone.0105701
Madsen SM, Arnau J, Vrang A, Givskov M, Israelsen H (1999) Molecular characterization of the pH-inducible and growth phase-dependent promoter P170 of Lactococcus lactis. Mol Microbiol 32(1):75–87
Maguin E, Duwat P, Hege T, Ehrlich D, Gruss A (1992) New thermosensitive plasmid for gram-positive bacteria. J Bacteriol 174(17):5633–5638
Mao R, Wu D, Wang Y (2016) Surface display on lactic acid bacteria without genetic modification: strategies and applications. Appl Microbiol Biotechnol 100(22):9407–9421. https://doi.org/10.1007/s00253-016-7842-8
Mao N, Cubillos-Ruiz A, Cameron DE, Collins JJ (2018) Probiotic strains detect and suppress cholera in mice. Sci Transl Med 10(445):eaao2586. https://doi.org/10.1126/scitranslmed.aao2586
Marelli B, Perez AR, Banchio C, de Mendoza D, Magni C (2011) Oral immunization with live Lactococcus lactis expressing rotavirus VP8 subunit induces specific immune response in mice. J Virol Methods 175(1):28–37. https://doi.org/10.1016/j.jviromet.2011.04.011
Martinez-Jaramillo E, Garza-Morales R, Loera-Arias MJ, Saucedo-Cardenas O, Montes-de-Oca-Luna R, McNally LR, Gomez-Gutierrez JG (2017) Development of Lactococcus lactis encoding fluorescent proteins, GFP, mCherry and iRFP regulated by the nisin-controlled gene expression system. Biotech Histochem 92(3):167–174. https://doi.org/10.1080/10520295.2017.1289554
Maxmen A (2017) Living therapeutics: scientists genetically modify bacteria to deliver drugs. Nat Med 23(1):5–7. https://doi.org/10.1038/nm0117-5
Michon C, Langella P, Eijsink VG, Mathiesen G, Chatel JM (2016) Display of recombinant proteins at the surface of lactic acid bacteria: strategies and applications. Microb Cell Factories 15:70. https://doi.org/10.1186/s12934-016-0468-9
Mierau I, Kleerebezem M (2005) 10 years of the nisin-controlled gene expression system (NICE) in Lactococcus lactis. Appl Microbiol Biotechnol 68(6):705–717. https://doi.org/10.1007/s00253-005-0107-6
Miyoshi A, Jamet E, Commissaire J, Renault P, Langella P, Azevedo V (2004) A xylose-inducible expression system for Lactococcus lactis. FEMS Microbiol Lett 239(2):205–212. https://doi.org/10.1016/j.femsle.2004.08.018
Mohamadzadeh M, Duong T, Sandwick SJ, Hoover T, Klaenhammer TR (2009) Dendritic cell targeting of Bacillus anthracis protective antigen expressed by Lactobacillus acidophilus protects mice from lethal challenge. Proc Natl Acad Sci U S A 106(11):4331–4336. https://doi.org/10.1073/pnas.0900029106
Mohamadzadeh M, Durmaz E, Zadeh M, Pakanati KC, Gramarossa M, Cohran V, Klaenhammer TR (2010) Targeted expression of anthrax protective antigen by Lactobacillus gasseri as an anthrax vaccine. Future Microbiol 5(8):1289–1296. https://doi.org/10.2217/fmb.10.78
de Moreno de LeBlanc A, LeBlanc JG, Perdigon G, Miyoshi A, Langella P, Azevedo V, Sesma F (2008) Oral administration of a catalase-producing Lactococcus lactis can prevent a chemically induced colon cancer in mice. J Med Microbiol 57(Pt 1):100–105. https://doi.org/10.1099/jmm.0.47403-0
Motta JP, Bermudez-Humaran LG, Deraison C, Martin L, Rolland C, Rousset P, Boue J, Dietrich G, Chapman K, Kharrat P, Vinel JP, Alric L, Mas E, Sallenave JM, Langella P, Vergnolle N (2012) Food-grade bacteria expressing elafin protect against inflammation and restore colon homeostasis. Sci Transl Med 4(158):158ra144. https://doi.org/10.1126/scitranslmed.3004212
Mu D, Montalban-Lopez M, Masuda Y, Kuipers OP (2013) Zirex: a novel zinc-regulated expression system for Lactococcus lactis. Appl Environ Microbiol 79(14):4503–4508
Neu T, Henrich B (2003) New thermosensitive delivery vector and its use to enable nisin-controlled gene expression in Lactobacillus gasseri. Appl Environ Microbiol 69(3):1377–1382
Ng DT, Sarkar CA (2013) Engineering signal peptides for enhanced protein secretion from Lactococcus lactis. Appl Environ Microbiol 79(1):347–356. https://doi.org/10.1128/AEM.02667-12
Oh JH, van Pijkeren JP (2014) CRISPR-Cas9-assisted recombineering in Lactobacillus reuteri. Nucleic Acids Res 42(17):e131
Ohkouchi K, Kawamoto S, Tatsugawa K, Yoshikawa N, Takaoka Y, Miyauchi S, Aki T, Yamashita M, Murooka Y, Ono K (2012) Prophylactic effect of Lactobacillus oral vaccine expressing a Japanese cedar pollen allergen. J Biosci Bioeng 113(4):536–541. https://doi.org/10.1016/j.jbiosc.2011.11.025
Ortiz-Velez L, Britton R (2017) Genetic tools for the enhancement of probiotic properties. Microbiol Spectr 5(5):BAD-0018-2016. https://doi.org/10.1128/microbiolspec.BAD-0018-2016
van Pijkeren JP, Britton RA (2012) High efficiency recombineering in lactic acid bacteria. Nucleic Acids Res 40(10):e76
Pinto JP, Zeyniyev A, Karsens H, Trip H, Lolkema JS, Kuipers OP, Kok J (2011) pSEUDO, a genetic integration standard for Lactococcus lactis. Appl Environ Microbiol 77(18):6687–6690
Ravn P, Arnau J, Madsen SM, Vrang A, Israelsen H (2003) Optimization of signal peptide SP310 for heterologous protein production in Lactococcus lactis. Microbiology 149(Pt 8):2193–2201. https://doi.org/10.1099/mic.0.26299-0
Reardon S (2018) Genetically modified bacteria enlisted in fight against disease. Nature 558(7711):497–498
Reese KA, Lupfer C, Johnson RC, Mitev GM, Mullen VM, Geller BL, Pastey M (2013) A novel lactococcal vaccine expressing a peptide from the M2 antigen of H5N2 highly pathogenic avian influenza a virus prolongs survival of vaccinated chickens. Vet Med Int 2013:316926
Robert S, Gysemans C, Takiishi T, Korf H, Spagnuolo I, Sebastiani G, Van Huynegem K, Steidler L, Caluwaerts S, Demetter P, Wasserfall CH, Atkinson MA, Dotta F, Rottiers P, Van Belle TL, Mathieu C (2014) Oral delivery of glutamic acid decarboxylase (GAD)-65 and IL10 by Lactococcus lactis reverses diabetes in recent-onset NOD mice. Diabetes 63(8):2876–2887. https://doi.org/10.2337/db13-1236
Robert S, Van Huynegem K, Gysemans C, Mathieu C, Rottiers P, Steidler L (2015) Trimming of two major type 1 diabetes driving antigens, GAD65 and IA-2, allows for successful expression in Lactococcus lactis. Benef Microbes 6(4):591–601. https://doi.org/10.3920/BM2014.0083
Robinson K, Chamberlain LM, Schofield KM, Wells JM, Le Page RW (1997) Oral vaccination of mice against tetanus with recombinant Lactococcus lactis. Nat Biotechnol 15(7):653–657. https://doi.org/10.1038/nbt0797-653
van Roosmalen ML, Kanninga R, El Khattabi M, Neef J, Audouy S, Bosma T, Kuipers A, Post E, Steen A, Kok J, Buist G, Kuipers OP, Robillard G, Leenhouts K (2006) Mucosal vaccine delivery of antigens tightly bound to an adjuvant particle made from food-grade bacteria. Methods 38(2):144–149. https://doi.org/10.1016/j.ymeth.2005.09.015
Rottiers P, Caluwaerts S, Steidler L, Vandenbroucke K, Watkins B, Sonis S, Coulie B (2009) Effect of a mouth rinse formulation with human trefoil factor 1-secreting Lactococcus lactis in experimental oral mucositis in hamsters. J Clin Oncol 27(15S):e14570–e14570. https://doi.org/10.1200/jco.2009.27.15s.e14570
Shigemori S, Shimosato T (2017) Applications of genetically modified immunobiotics with high immunoregulatory capacity for treatment of inflammatory bowel diseases. Front Microbiol 8:22. https://doi.org/10.3389/fimmu.2017.00022
Shigemori S, Watanabe T, Kudoh K, Ihara M, Nigar S, Yamamoto Y, Suda Y, Sato T, Kitazawa H, Shimosato T (2015) Oral delivery of Lactococcus lactis that secretes bioactive heme oxygenase-1 alleviates development of acute colitis in mice. Microb Cell Factories 14:189. https://doi.org/10.1186/s12934-015-0378-2
Shigemori S, Ihara M, Sato T, Yamamoto Y, Nigar S, Ogita T, Shimosato T (2017) Secretion of an immunoreactive single-chain variable fragment antibody against mouse interleukin 6 by Lactococcus lactis. Appl Microbiol Biotechnol 101(1):341–349. https://doi.org/10.1007/s00253-016-7907-8
Skrlec K, Pucer Janez A, Rogelj B, Strukelj B, Berlec A (2017) Evasin-displaying lactic acid bacteria bind different chemokines and neutralize CXCL8 production in Caco-2 cells. Microb Biotechnol 10(6):1732–1743. https://doi.org/10.1111/1751-7915.12781
Skrlec K, Zadravec P, Hlavnickova M, Kuchar M, Vankova L, Petrokova H, Krizova L, Cerny J, Berlec A, Maly P (2018) p19-targeting ILP protein blockers of IL-23/Th-17 pro-inflammatory axis displayed on engineered bacteria of food origin. Int J Mol Sci 19(7):e1933. https://doi.org/10.3390/ijms19071933
Škrlec K, Ručman R, Jarc E, Sikirić P, Švajger U, Petan T, Perišić Nanut M, Štrukelj B, Berlec A (2018) Engineering recombinant Lactococcus lactis as a delivery vehicle for BPC-157 peptide with antioxidant activities. Appl Microbiol Biotechnol 102:10103–10117. https://doi.org/10.1007/s00253-018-9333-6
Song AA, In LLA, Lim SHE, Rahim RA (2017a) A review on Lactococcus lactis: from food to factory. Microb Cell Factories 16(1):55. https://doi.org/10.1186/s12934-017-0669-x
Song X, Huang H, Xiong Z, Ai L, Yang S (2017b) CRISPR-Cas9(D10A) nickase-assisted genome editing in Lactobacillus casei. Appl Environ Microbiol:83(22):e01259-17. https://doi.org/10.1128/AEM.01259-17
Sorvig E, Mathiesen G, Naterstad K, Eijsink VG, Axelsson L (2005) High-level, inducible gene expression in Lactobacillus sakei and Lactobacillus plantarum using versatile expression vectors. Microbiology 151(Pt 7):2439–2449. https://doi.org/10.1099/mic.0.28084-0
Steidler L, Neirynck S, Huyghebaert N, Snoeck V, Vermeire A, Goddeeris B, Cox E, Remon JP, Remaut E (2003) Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10. Nat Biotechnol 21(7):785–789. https://doi.org/10.1038/nbt840
Stentz R, Jury K, Eaton T, Parker M, Narbad A, Gasson M, Shearman C (2004) Controlled expression of CluA in Lactococcus lactis and its role in conjugation. Microbiology 150(Pt 8):2503–2512
Szatraj K, Szczepankowska AK, Chmielewska-Jeznach M (2017) Lactic acid bacteria—promising vaccine vectors: possibilities, limitations, doubts. J Appl Microbiol 123(2):325–339. https://doi.org/10.1111/jam.13446
Takiishi T, Cook DP, Korf H, Sebastiani G, Mancarella F, Cunha JP, Wasserfall C, Casares N, Lasarte JJ, Steidler L, Rottiers P, Dotta F, Gysemans C, Mathieu C (2017) Reversal of diabetes in NOD mice by clinical-grade proinsulin and IL-10-secreting Lactococcus lactis in combination with low-dose anti-CD3 depends on the induction of Foxp3-positive T cells. Diabetes 66(2):448–459
Toscano M, De Grandi R, Miniello VL, Mattina R, Drago L (2017) Ability of Lactobacillus kefiri LKF01 (DSM32079) to colonize the intestinal environment and modify the gut microbiota composition of healthy individuals. Dig Lives Dis 49(3):261–267. https://doi.org/10.1016/j.dld.2016.11.011
Van Braeckel-Budimir N, Haijema BJ, Leenhouts K (2013) Bacterium-like particles for efficient immune stimulation of existing vaccines and new subunit vaccines in mucosal applications. Front Immunol 4:282
Vandenbroucke K, de Haard H, Beirnaert E, Dreier T, Lauwereys M, Huyck L, Van Huysse J, Demetter P, Steidler L, Remaut E, Cuvelier C, Rottiers P (2010) Orally administered L. lactis secreting an anti-TNF Nanobody demonstrate efficacy in chronic colitis. Mucosal Immunol 3(1):49–56. https://doi.org/10.1038/mi.2009.116
Visweswaran GR, Leenhouts K, van Roosmalen M, Kok J, Buist G (2014) Exploiting the peptidoglycan-binding motif, LysM, for medical and industrial applications. Appl Microbiol Biotechnol 98(10):4331–4345. https://doi.org/10.1007/s00253-014-5633-7
Volzing K, Borrero J, Sadowsky MJ, Kaznessis YN (2013) Antimicrobial peptides targeting gram-negative pathogens, produced and delivered by lactic acid bacteria. ACS Synth Biol 2(11):643–650
de Vos WM (1999) Gene expression systems for lactic acid bacteria. Curr Opin Microbiol 2(3):289–295. https://doi.org/10.1016/S1369-5274(99)80050-2
Walker DC, Klaenhammer TR (1994) Isolation of a novel IS3 group insertion element and construction of an integration vector for Lactobacillus spp. J Bacteriol 176(17):5330–5340
Wang Z, Yu Q, Gao J, Yang Q (2012) Mucosal and systemic immune responses induced by recombinant lactobacillus spp. expressing the hemagglutinin of the avian influenza virus H5N1. Clin Vaccine Immunol 19(2):174–179. https://doi.org/10.1128/CVI.05618-11
Wang M, Gao Z, Zhang Y, Pan L (2016) Lactic acid bacteria as mucosal delivery vehicles: a realistic therapeutic option. Appl Microbiol Biotechnol 100(13):5691–5701. https://doi.org/10.1007/s00253-016-7557-x
Watterlot L, Rochat T, Sokol H, Cherbuy C, Bouloufa I, Lefevre F, Gratadoux JJ, Honvo-Hueto E, Chilmonczyk S, Blugeon S, Corthier G, Langella P, Bermudez-Humaran LG (2010) Intragastric administration of a superoxide dismutase-producing recombinant Lactobacillus casei BL23 strain attenuates DSS colitis in mice. Int J Food Microbiol 144(1):35–41. https://doi.org/10.1016/j.ijfoodmicro.2010.03.037
Wells JM, Wilson PW, Norton PM, Gasson MJ, Le Page RW (1993) Lactococcus lactis: high-level expression of tetanus toxin fragment C and protection against lethal challenge. Mol Microbiol 8(6):1155–1162
Wong CC, Zhang L, Li ZJ, Wu WK, Ren SX, Chen YC, Ng TB, Cho CH (2012) Protective effects of cathelicidin-encoding Lactococcus lactis in murine ulcerative colitis. J Gastroenterol Hepatol 27(7):1205–1212. https://doi.org/10.1111/j.1440-1746.2012.07158.x
Wong CC, Zhang L, Wu WK, Shen J, Chan RL, Lu L, Hu W, Li MX, Li LF, Ren SX, Li YF, Li J, Cho CH (2017) Cathelicidin-encoding Lactococcus lactis promotes mucosal repair in murine experimental colitis. J Gastroenterol Hepatol 32(3):609–619
Wu CM, Lin CF, Chang YC, Chung TC (2006) Construction and characterization of nisin-controlled expression vectors for use in Lactobacillus reuteri. Biosci Biotechnol Biochem 70(4):757–767. https://doi.org/10.1271/bbb.70.757
Yagnik B, Padh H, Desai P (2016) Construction of a new shuttle vector for DNA delivery into mammalian cells using non-invasive Lactococcus lactis. Microbes Infect 18(4):237–244
Yagnik B, Sharma D, Padh H, Desai P (2017) Immunization with r-Lactococcus lactis expressing outer membrane protein a of Shigella dysenteriae type-1: evaluation of oral and intranasal route of administration. J Appl Microbiol 122(2):493–505
Yoon SW, Lee CH, Kim JY, Kim JY, Sung MH, Poo H (2008) Lactobacillus casei secreting alpha-MSH induces the therapeutic effect on DSS-induced acute colitis in BALB/c mice. J Microbiol Biotechnol 18(12):1975–1983
Yu D, Sawitzke JA, Ellis H, Court DL (2003) Recombineering with overlapping single-stranded DNA oligonucleotides: testing a recombination intermediate. Proc Natl Acad Sci U S A 100(12):7207–7212. https://doi.org/10.1073/pnas.1232375100
Zadravec P, Mavrič A, Bogovič Matijašić B, Štrukelj B, Berlec A (2014) Engineering BmpA as a carrier for surface display of IgG-binding domain on Lactococcus lactis. Protein Eng Des Sel 27(1):21–27
Zadravec P, Strukelj B, Berlec A (2015a) Heterologous surface display on lactic acid bacteria: non-GMO alternative? Bioengineered 6(3):179–183. https://doi.org/10.1080/21655979.2015.1040956
Zadravec P, Strukelj B, Berlec A (2015b) Improvement of LysM-mediated surface display of designed ankyrin repeat proteins (DARPins) in recombinant and nonrecombinant strains of Lactococcus lactis and Lactobacillus species. Appl Environ Microbiol 81(6):2098–2106. https://doi.org/10.1128/AEM.03694-14
Zadravec P, Mareckova L, Petrokova H, Hodnik V, Perisic Nanut M, Anderluh G, Strukelj B, Maly P, Berlec A (2016) Development of recombinant Lactococcus lactis displaying albumin-binding domain variants against Shiga toxin 1 B subunit. PLoS One 11(9):e0162625. https://doi.org/10.1371/journal.pone.0162625
Zahirovic A, Lunder M (2018) Microbial delivery vehicles for allergens and allergen-derived peptides in immunotherapy of allergic diseases. Front Microbiol 9:1449. https://doi.org/10.3389/fmicb.2018.01449
Zeng Z, Yu R, Zuo F, Zhang B, Peng D, Ma H, Chen S (2016) Heterologous expression and delivery of biologically active exendin-4 by Lactobacillus paracasei L14. PLoS One 11(10):e0165130. https://doi.org/10.1371/journal.pone.0165130
Zhang L, Zhang Y, Zhong W, Di C, Lin X, Xia Z (2014) Heme oxygenase-1 ameliorates dextran sulfate sodium-induced acute murine colitis by regulating Th17/Treg cell balance. J Biol Chem 289(39):26847–26858. https://doi.org/10.1074/jbc.M114.590554
Zhang B, Li A, Zuo F, Yu R, Zeng Z, Ma H, Chen S (2016a) Recombinant Lactococcus lactis NZ9000 secretes a bioactive kisspeptin that inhibits proliferation and migration of human colon carcinoma HT-29 cells. Microb Cell Factories 15(1):102
Zhang L, Wu WK, Gallo RL, Fang EF, Hu W, Ling TK, Shen J, Chan RL, Lu L, Luo XM, Li MX, Chan KM, Yu J, Wong VW, Ng SC, Wong SH, Chan FK, Sung JJ, Chan MT, Cho CH (2016b) Critical role of antimicrobial peptide cathelicidin for controlling Helicobacter pylori survival and infection. J Immunol 196(4):1799–1809
Zhu D, Liu F, Xu H, Bai Y, Zhang X, Saris PE, Qiao M (2015) Isolation of strong constitutive promoters from Lactococcus lactis subsp. lactis N8. FEMS Microbiol Lett 362(16):fnv107. https://doi.org/10.1093/femsle/fnv107
Zhu D, Fu Y, Liu F, Xu H, Saris PE, Qiao M (2017) Enhanced heterologous protein productivity by genome reduction in Lactococcus lactis NZ9000. Microb Cell Factories 16(1):1
Funding
This work was supported by the Slovenian Research Agency (grant numbers P4-0127 and J4-9327).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
This article does not contain studies with human participants or animals performed by any of authors.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Plavec, T.V., Berlec, A. Engineering of lactic acid bacteria for delivery of therapeutic proteins and peptides. Appl Microbiol Biotechnol 103, 2053–2066 (2019). https://doi.org/10.1007/s00253-019-09628-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00253-019-09628-y